首页> 外文期刊>British Journal of Cancer >Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9
【24h】

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9

机译:肿瘤相关抗原CA242在良性和恶性胰腺病变中的组织表达。与CA 50和CA 19-9的比较

获取原文
           

摘要

The expression of a novel tumour associated antigen CA 242, defined by the monoclonal antibody C 242, was studied by immunoperoxidase staining in formalin-fixed, paraffin-embedded tissue sections from normal pancreata, pancreata with pancreatitis and benign and malignant pancreatic neoplasms. The antigenic determinant of the C 242 antibody is a sialylated carbohydrate structure, related but chemically different from tumour marker antigens CA 19-9 and CA 50. Thirty-eight of 41 (93%) well to moderately differentiated ductal adenocarcinomas of the pancreas and all cystadenocarcinomas were positive for CA 242. The staining was most intense in the apical border of the cells, and in the intraluminal mucus. Only two out of seven poorly differentiated adenocarcinomas stained, and the number of positive cells was smaller than in well differentiated carcinomas. Only occasional cells were stained in one out of five anaplastic carcinomas. Part of large ducts were positive in 91% (21/23) specimens of chronic pancreatitis. In acute pancreatitis small terminal ducts, centro-acinar cells and some large ducts stained for CA 242. In normal pancreas only a few small terminal ducts were CA 242 positive. Carcinomas always stained more strongly for CA 242 than normal pancreatic tissue adjacent to the carcinoma. The results of CA 242 are compared with those of tumour marker antigens CA 50 and CA 19-9. Serum CA 242 levels were determined in 23 of the patients with pancreatic cancer using a fluoroimmunoassay. Fifteen (65%) patients had an elevated value. There was no clear-cut correlation between the serum levels and the immunohistochemical expression of the CA 242 antigen. The expression of CA 242 in pancreatic tissue resembles that of CA 50 and is similar to CA 19-9. The antigen is expressed in serum of many patients with pancreatic cancer and, therefore, is a potential candidate for a serum tumour marker.
机译:通过免疫过氧化物酶染色研究了正常胰腺,患有胰腺炎的胰腺以及良性和恶性胰腺肿瘤的福尔马林固定,石蜡包埋的组织切片中由单克隆抗体C 242定义的新型肿瘤相关抗原CA 242的表达。 C 242抗体的抗原决定簇是唾液酸化的碳水化合物结构,与肿瘤标志物抗原CA 19-9和CA 50相关但化学上不同。38个胰腺癌(41%)(93%)完全分化为中度分化的胰腺腺癌膀胱腺癌CA 242阳性。在细胞的顶端边界和腔内粘液中染色最强烈。在七个低分化的腺癌中,只有两个被染色,阳性细胞的数量少于高分化的腺癌。五分之一的间变性癌中只有偶尔的细胞被染色。 91%(21/23)的慢性胰腺炎标本中的大导管阳性。在急性胰腺炎中,小末端导管,中心腺泡细胞和一些大导管被CA 242染色。在正常胰腺中,只有少数几个小末端导管为CA 242阳性。 CA 242的癌总是比癌旁的正常胰腺组织染色更强。将CA 242的结果与肿瘤标志物抗原CA 50和CA 19-9的结果进行比较。使用荧光免疫测定法测定了23名胰腺癌患者的血清CA 242水平。 15名(65%)患者的血红蛋白升高。血清水平与CA 242抗原的免疫组化表达之间没有明确的相关性。胰腺组织中CA 242的表达类似于CA 50的表达,与CA 19-9相似。该抗原在许多胰腺癌患者的血清中表达,因此是血清肿瘤标志物的潜在候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号